NCT00729599View on ClinicalTrials.gov

Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.

PHASE3CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2008

Conditions

Hygiene

Interventions

DRUG

Cetylpyridinium chloride

Cetylpyridinium chloride during 21 consecutive days.

Trial Locations (1)

Unknown

Sanofi-aventis, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY